Birgit Friedmann leads the regional Market Access Team and is engaged in market access projects on a national and international basis. Her responsibilities include market access strategy consulting, patient support programs, execution of market access activities on behalf of clients in the outpatient setting as well as in the hospital area in a variety of indications for Rx, Orphans, Biosimilars, ATMPs, Medical devices and OTC drugs.
Birgit has more than 20 years experience in the pharmaceutical industry with focus on Market Access, New Product Development and Business Development. Prior to Quintiles, Birgit was a Business Development & Market Access Director at Merz Pharmaceuticals with focus on Alzheimer's disease and Dermatology for Germany, Austria and Switzerland. She was also a licencing manager at Knoll AG (now part of AbbVie) and a New Product Development Manager at Pfizer, where she was part of the global planning network working on products from Phase I to launch.
Birgit is a native German speaker. She got her Master in Biology and the PhD in Immunology in Germany. Following a post-doc at the Harvard Medical School in Boston, she added an MBA with international concentration at Babson, Wellesley.